Provided By GlobeNewswire
Last update: Nov 11, 2025
Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East
Read more at globenewswire.comNASDAQ:PROF (12/15/2025, 8:00:02 PM)
7.69
+0.36 (+4.91%)
Find more stocks in the Stock Screener


